Your browser doesn't support javascript.
loading
ETS1 phosphorylation at threonine 38 is associated with the cell of origin of diffuse large B cell lymphoma and sustains the growth of tumour cells.
Chung, Elaine Y L; Sartori, Giulio; Ponzoni, Maurilio; Cascione, Luciano; Priebe, Valdemar; Xu-Monette, Zijun Y; Fang, Xiaosheng; Zhang, Mingzhi; Visco, Carlo; Tzankov, Alexandar; Rinaldi, Andrea; Sgrignani, Jacopo; Zucca, Emanuele; Rossi, Davide; Cavalli, Andrea; Inghirami, Giorgio; Scott, David W; Young, Ken H; Bertoni, Francesco.
Afiliação
  • Chung EYL; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.
  • Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.
  • Ponzoni M; IRCCS San Raffaele Hospital Scientific Institute, Vita Salute San Raffaele University, Milan, Italy.
  • Cascione L; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.
  • Priebe V; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Xu-Monette ZY; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.
  • Fang X; Duke University Medical Center, Durham, North Carolina, USA.
  • Zhang M; Duke University Medical Center, Durham, North Carolina, USA.
  • Visco C; Duke University Medical Center, Durham, North Carolina, USA.
  • Tzankov A; Section of Hematology, Department of Medicine, University of Verona, Verona, Italy.
  • Rinaldi A; Pathology, Institute of Medical Genetics and Pathology, University Hospital, Basel, Switzerland.
  • Sgrignani J; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.
  • Zucca E; Faculty of Biomedical Sciences, Institute for Research in Biomedicine, USI, Bellinzona, Switzerland.
  • Rossi D; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Cavalli A; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland.
  • Inghirami G; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Scott DW; Faculty of Biomedical Sciences, Institute for Research in Biomedicine, USI, Bellinzona, Switzerland.
  • Young KH; Pathology and Laboratory Medicine Department, Weill Cornell Medicine, New York, New York, USA.
  • Bertoni F; Centre for Lymphoid Cancer, BC Cancer, University of British Columbia, Vancouver, British Columbia, Canada.
Br J Haematol ; 203(2): 244-254, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37584198
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Br J Haematol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça